Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Operating Income of -$183.9 thousand for fiscal year 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$183.9K | -180.7% |
| 2023 | $227.8K | +154.9% |
| 2022 | -$415.1K | -247.7% |
| 2021 | -$119.4K | — |
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -180.7% in Operating Income compared to the prior fiscal year.
- Over the 2021–2024 period, Cordyceps Sunshine Biotech Holdings Co., Ltd.’s operating income has declined by 54.0% (from -$119.4 thousand to -$183.9 thousand).
- The most recent figure is from Cordyceps Sunshine Biotech Holdings Co., Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on June 13, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: